Myopia Recruiting Phase 2 Trials for Atropine (DB00572)

Also known as: Short-sighted / Short sightedness / Nearsighted

IndicationStatusPhase
DBCOND0009460 (Myopia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03911271Low-dose Atropine for the Prevention of Myopia Progression in Danish ChildrenTreatment
NCT03690089Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United KingdomTreatment